In 2021, a 56-year-old women was reported with an MSH2 mutation and aggressive prolactinoma, and another carrying the same mutation was diagnosed with an invasive corticotropinoma [90,93]. Here, MSH2 is linked to ACTH-producing pituitary gland adenoma.